期刊： JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022; 13 (2)
Background: Malignant primary gastric gastrointestinal stromal tumors (gGISTs) without treatment with imatinib are prone to bleeding and peritoneum im......
期刊： JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022; 13 (3)
Background: Local recurrence of colorectal cancer is associated with poor prognosis and quality of life. For patients not eligible for curative surger......
期刊： JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022; 13 (5)
Background: Colorectal cancer (CRC) is one of the most common malignant tumors of the digestive tract. Surgery is the main way to cure CRC, but the po......
期刊： JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022; 13 (5)
Background: Sodium-glucose co-transporters-2 (SGLT-2) has been reported as overexpressed in tumors including pancreatic cancer (PC). The aim of this s......
期刊： JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022; 13 (5)
Background: This study sought to explore the role and significance of multidisciplinary team (MDT) discussion and comprehensive treatment in the diagn......
期刊： JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022; 13 (5)
Background: Colorectal cancer (CRC) is one of the most common malignancies. Although CRC treatment has been significantly improved, patient survival r......
期刊： JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022; 13 (3)
Background: Zinc finger of the cerebellum 5 (ZIC5) has been found to be abnormally expressed in a variety of tumors. This study aimed to reveal the ex......
期刊： JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022; 13 (5)
Background: Glypican 1 (GPC1) is a heparan sulphate proteoglycan cell membrane protein. It is implicated in driving cancers of the breast, brain, panc......
期刊： JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022; 13 (4)
Background: Previous studies have shown that PD-L1-positive advanced gastric cancer (GC) patients could achieve clinical benefit after receiving immun......
期刊： JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022; 13 (5)
Background: Esophageal cancer (EC) is one of the most lethal cancers. Esophageal squamous cell carcinoma (ESCC) is the most common histological subtyp......
期刊： JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022; 13 (1)
Background: The current study analysed rectal neuroendocrine tumour (RNET) patients undergoing resection to identify predictive factors and construct ......
期刊： JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022; 13 (1)
Background: To evaluate the cost-effectiveness of camrelizumab versus chemotherapy for patients with advanced or metastatic esophageal squamous cell c......
期刊： JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022; 13 (2)
Background: Single-drug albumin-bound paclitaxel is one of the standard second-line treatments for advanced gastric cancer. Some clinical studies sugg......
期刊： JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022; 13 (3)
Background: We aimed to screen the key pathogenic transcription factors of gastric cancer and analyzed the correlation between the expression of trans......
期刊： JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022; 13 (3)
Background: To explore the white light endoscopy and endoscopic ultrasonography (EUS) features of rectal hyperplastic polyps (rHP) misdiagnosed as rec......
